L04AB01 • etanercept • Antineoplastic and immunomodulating agents | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors
Etanercept is a biological medication used in the treatment of autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, or psoriasis. It works by blocking a protein involved in the inflammatory process, thus reducing inflammation, pain, and joint damage.
Etanercept is administered as subcutaneous injections, usually once or twice a week, according to the doctor's instructions. The dose and frequency of treatment are determined individually, depending on the condition being treated and the patient's response.
Side effects may include injection site reactions, respiratory infections, headaches, or, rarely, severe allergic reactions. Medical monitoring is necessary throughout the treatment to prevent complications.
Etanercept is an effective option for patients with autoimmune diseases, helping to improve quality of life and reduce symptoms in the long term.
Substance: etanercept
Date of last drug list: 01-01-2015
Commercial code: W61302003
Concentration: 50mg
Pharmaceutical form: powder for injection
Quantity: 12
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).